Status:
TERMINATED
Short-Course Isoniazid and Rifampin Compared With Isoniazid for Latent Tuberculosis Infection
Lead Sponsor:
Hospital Virgen de la Luz
Conditions:
Tuberculosis
Eligibility:
All Genders
16-89 years
Phase:
PHASE4
Brief Summary
The objective of the study was to compare the compliance and the side effects of a short course to treatment of latent tuberculosis infection during 3 months(isoniazid plus rifampin)group I, with the ...
Detailed Description
Introduction: The objective of the study was to compare the compliance and the side effects of a short course to treatment of latent tuberculosis infection during 3 months with the standard course for...
Eligibility Criteria
Inclusion
- patients with positive TST and the suitable criteria for treatment, in accordance with the guidelines of the CDC:
Exclusion
- HIV infection.
- Hepatopathy
- Previous treatment of of latent tuberculosis infection.
- Allergy to drugs.
Key Trial Info
Start Date :
March 1 1996
Trial Type :
INTERVENTIONAL
End Date :
February 1 2006
Estimated Enrollment :
228 Patients enrolled
Trial Details
Trial ID
NCT00397709
Start Date
March 1 1996
End Date
February 1 2006
Last Update
December 31 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maria Paloma Geijo Martinez. Hospital Virgen de la Luz
Cuenca, Cuenca, Spain, 16002